Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Exchange Rate Effect (2017 - 2025)

Ultragenyx Pharmaceutical has reported Exchange Rate Effect over the past 9 years, most recently at -$656000.0 for Q4 2025.

  • Quarterly Exchange Rate Effect rose 66.32% to -$656000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 million through Dec 2025, up 300.0% year-over-year, with the annual reading at $4.0 million for FY2025, 300.0% up from the prior year.
  • Exchange Rate Effect was -$656000.0 for Q4 2025 at Ultragenyx Pharmaceutical, down from $294000.0 in the prior quarter.
  • Over five years, Exchange Rate Effect peaked at $2.9 million in Q2 2025 and troughed at -$1.9 million in Q4 2024.
  • The 5-year median for Exchange Rate Effect is -$264000.0 (2021), against an average of -$13450.0.
  • Year-over-year, Exchange Rate Effect tumbled 421.8% in 2024 and then surged 549.69% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at -$392000.0 in 2021, then skyrocketed by 444.9% to $1.4 million in 2022, then crashed by 52.59% to $641000.0 in 2023, then crashed by 403.9% to -$1.9 million in 2024, then skyrocketed by 66.32% to -$656000.0 in 2025.
  • Per Business Quant, the three most recent readings for RARE's Exchange Rate Effect are -$656000.0 (Q4 2025), $294000.0 (Q3 2025), and $2.9 million (Q2 2025).